Last reviewed · How we verify
Desogestrel medium follicular phase
Desogestrel is a progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions.
Desogestrel is a progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions. Used for Contraception / prevention of pregnancy.
At a glance
| Generic name | Desogestrel medium follicular phase |
|---|---|
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Drug class | Progestin (hormonal contraceptive) |
| Target | Progesterone receptor |
| Modality | Small molecule |
| Therapeutic area | Contraception / Reproductive Health |
| Phase | Phase 3 |
Mechanism of action
Desogestrel is a third-generation synthetic progestin used in hormonal contraceptives. It works primarily by inhibiting the luteinizing hormone (LH) surge needed to trigger ovulation. Additionally, it increases cervical mucus viscosity to impede sperm penetration and alters the endometrium to reduce implantation likelihood. The 'medium follicular phase' designation refers to the timing or dosing regimen within a multiphasic oral contraceptive formulation.
Approved indications
- Contraception / prevention of pregnancy
Common side effects
- Nausea
- Headache
- Breast tenderness
- Breakthrough bleeding
- Mood changes
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: